IR-Med, Inc. financial data

Symbol
IRME on OTC
Location
C/O Aboudi Legal Group Pllc, 745 5 Th Ave, Suite 500, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 312 %
Debt-to-equity -177 % -238%
Return On Equity 667 %
Return On Assets -868 % -165%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 77.2M shares +9.19%
Common Stock, Shares, Outstanding 77.2M shares
Entity Public Float 24.4M USD -39.3%
Common Stock, Value, Issued 77K USD +10%
Weighted Average Number of Shares Outstanding, Basic 73.8M shares +4.94%
Weighted Average Number of Shares Outstanding, Diluted 73.8M shares +4.94%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 535K USD -57.2%
General and Administrative Expense 902K USD -41.5%
Operating Income (Loss) -1.46M USD +57.9%
Nonoperating Income (Expense) -913K USD -45750%
Net Income (Loss) Attributable to Parent -2.35M USD +32.3%
Earnings Per Share, Basic 0 USD/shares +40%
Earnings Per Share, Diluted 0 USD/shares +40%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 63K USD -91.6%
Accounts Receivable, after Allowance for Credit Loss, Current 27K USD -25%
Assets, Current 90K USD -88.6%
Property, Plant and Equipment, Net 29K USD -31%
Operating Lease, Right-of-Use Asset 45K USD 0%
Assets 175K USD -80.3%
Accounts Payable, Current 139K USD
Employee-related Liabilities, Current 26K USD
Accrued Liabilities, Current 147K USD
Liabilities, Current 774K USD
Long-term Debt and Lease Obligation 13K USD -83.3%
Operating Lease, Liability, Noncurrent 26K USD
Liabilities 800K USD +52.7%
Retained Earnings (Accumulated Deficit) -18.2M USD -14.8%
Stockholders' Equity Attributable to Parent -625K USD -272%
Liabilities and Equity 175K USD -80.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -110K USD +69.3%
Net Cash Provided by (Used in) Financing Activities 31K USD
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 77.2M shares +9.25%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -78K USD +78.3%
Deferred Tax Assets, Valuation Allowance 2.34M USD +11.7%
Deferred Tax Assets, Gross 2.34M USD +10.7%
Operating Lease, Liability 39K USD -65.8%
Depreciation 3K USD -66.7%
Lessee, Operating Lease, Liability, to be Paid 50K USD -58.3%
Property, Plant and Equipment, Gross 93K USD 0%
Operating Lease, Liability, Current 16K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11K USD +83.3%
Deferred Tax Assets, Operating Loss Carryforwards 2.18M USD +30%
Additional Paid in Capital 17.5M USD +8.39%